The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc. | COM | 00289Y107 | 31,452 | 1,984,364 | SH | SOLE | 1,984,364 | 0 | 0 | ||
Ablynx NV | SPONSORED ADR | 00372Y105 | 103,986 | 4,161,118 | SH | SOLE | 4,161,118 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 819,845 | 27,228,338 | SH | SOLE | 27,228,338 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 6,956 | 163,900 | SH | SOLE | 163,900 | 0 | 0 | ||
Achaogen, Inc. | COM | 004449104 | 1,315 | 122,482 | SH | SOLE | 122,482 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 8,227 | 2,856,637 | SH | SOLE | 2,856,637 | 0 | 0 | ||
Acorda Therapeutics, Inc. | COM | 00484M106 | 4,418 | 205,966 | SH | SOLE | 205,966 | 0 | 0 | ||
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 5,850 | 172,630 | SH | SOLE | 172,630 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 668 | 100,000 | SH | SOLE | 600,000 | 0 | 0 | ||
Advanced Accelerator Applications S.A. | SPONSORED ADS | 00790T100 | 4,499 | 55,125 | SH | SOLE | 110,250 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 6,156 | 1,137,872 | SH | SOLE | 1,137,872 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 17,887 | 299,356 | SH | SOLE | 299,356 | 0 | 0 | ||
Aevi Genomic Medicine, Inc. | COM | 00835P105 | 4,866 | 4,055,142 | SH | SOLE | 4,055,142 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 520 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 7,356 | 128,666 | SH | SOLE | 128,666 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 25,487 | 673,908 | SH | SOLE | 673,908 | 0 | 0 | ||
Akari Therapeutics Plc | SPONSORED ADR | 00972G108 | 3,018 | 696,901 | SH | SOLE | 69,690,100 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 5,120 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 1,022,957 | 8,553,864 | SH | SOLE | 8,553,864 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 8,223 | 150,251 | SH | SOLE | 150,251 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | 90,905 | 22,669,509 | SH | SOLE | 22,669,509 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 18,269 | 181,386 | SH | SOLE | 181,386 | 0 | 0 | ||
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 128,586 | 10,934,154 | SH | SOLE | 10,934,154 | 0 | 0 | ||
Arbutus Biopharma Corporation | COM | 03879J100 | 912 | 180,582 | SH | SOLE | 180,582 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 60,725 | 961,754 | SH | SOLE | 961,754 | 0 | 0 | ||
Array BioPharma Inc. | COM | 04269X105 | 72,399 | 5,656,196 | SH | SOLE | 5,656,196 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 104,910 | 2,618,818 | SH | SOLE | 2,618,818 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 14,603 | 322,727 | SH | SOLE | 322,727 | 0 | 0 | ||
AveXis, Inc. | COM | 05366U100 | 85,769 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 376,147 | 3,849,231 | SH | SOLE | 50,040,003 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 42,322 | 5,032,313 | SH | SOLE | 5,032,313 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 68,726 | 13,997,172 | SH | SOLE | 13,997,172 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | COM | 09060J106 | 620 | 210,021 | SH | SOLE | 210,021 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 676,184 | 7,583,084 | SH | SOLE | 7,583,084 | 0 | 0 | ||
BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | 2 | 20,084 | SH | SOLE | 20,084 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 35,620 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 22,882 | 5,852,153 | SH | SOLE | 5,852,153 | 0 | 0 | ||
Cellectis S.A. | SPONSORED ADS | 15117K103 | 1,458 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 32,939 | 9,745,209 | SH | SOLE | 9,745,209 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 292 | 49,064 | SH | SOLE | 49,064 | 0 | 0 | ||
Clementia Pharmaceuticals Inc. | COM | 185575107 | 4,745 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ContraFect Corporation | COM | 212326102 | 7,225 | 7,153,076 | SH | SOLE | 7,153,076 | 0 | 0 | ||
Corbus Pharmaceuticals Holdings, Inc. | COM | 21833P103 | 4,691 | 660,714 | SH | SOLE | 660,714 | 0 | 0 | ||
Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | 92 | 13,253 | SH | SOLE | 13,253 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 27,524 | 2,991,775 | SH | SOLE | 2,991,775 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 135,535 | 5,509,560 | SH | SOLE | 2,754,780 | 0 | 0 | ||
Dynavax Technologies Corporation | COM NEW | 268158201 | 1,403 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Endocyte, Inc. | COM | 29269A102 | 4,654 | 1,087,323 | SH | SOLE | 1,087,323 | 0 | 0 | ||
Epizyme, Inc. | COM | 29428V104 | 2,918 | 232,481 | SH | SOLE | 232,481 | 0 | 0 | ||
Erytech Pharma S.A. | SPONSORED ADR | 29604W108 | 68,043 | 3,090,069 | SH | SOLE | 3,090,069 | 0 | 0 | ||
Exelixis, Inc. | COM | 30161Q104 | 45,798 | 1,506,499 | SH | SOLE | 1,506,499 | 0 | 0 | ||
Five Prime Therapeutics, Inc. | COM | 33830X104 | 422 | 19,247 | SH | SOLE | 19,247 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 14,825 | 2,466,702 | SH | SOLE | 2,466,702 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 548 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Galapagos NV | SPONSORED ADR | 36315X101 | 24,368 | 259,894 | SH | SOLE | 259,894 | 0 | 0 | ||
Genomic Health, Inc. | COM | 37244C101 | 471,314 | 13,781,102 | SH | SOLE | 13,781,102 | 0 | 0 | ||
GlycoMimetics, Inc. | COM | 38000Q102 | 9,458 | 563,312 | SH | SOLE | 563,312 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 29,280 | 221,800 | SH | SOLE | 2,661,600 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | COM | 40637H109 | 32,040 | 1,581,424 | SH | SOLE | 1,581,424 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 55,398 | 3,060,641 | SH | SOLE | 3,060,641 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | 38,646 | 18,315,802 | SH | SOLE | 18,315,802 | 0 | 0 | ||
Ignyta, Inc. | COM | 451731103 | 36,960 | 1,384,266 | SH | SOLE | 1,384,266 | 0 | 0 | ||
Immune Design Corp. | COM | 45252L103 | 581 | 148,937 | SH | SOLE | 148,937 | 0 | 0 | ||
ImmunoGen, Inc. | COM | 45253H101 | 16,432 | 2,563,489 | SH | SOLE | 2,563,489 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 3,241,973 | 34,230,523 | SH | SOLE | 34,230,523 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 1,178 | 580,400 | SH | SOLE | 580,400 | 0 | 0 | ||
InflaRx N.V. | COM | N44821101 | 4,190 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 21,826 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Intellia Therapeutics, Inc. | COM | 45826J105 | 22,016 | 1,145,453 | SH | SOLE | 1,145,453 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | COM | 46116X101 | 8,821 | 609,166 | SH | SOLE | 609,166 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 66,178 | 7,288,300 | SH | SOLE | 7,288,300 | 0 | 0 | ||
InVivo Therapeutics Holdings Corp. | COM NEW | 46186M209 | 255 | 331,393 | SH | SOLE | 331,393 | 0 | 0 | ||
Jounce Therapeutics, Inc. | COM | 481116101 | 1,275 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | COM | 48576U106 | 2,083 | 216,990 | SH | SOLE | 216,990 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 2,104 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 4,977 | 154,675 | SH | SOLE | 154,675 | 0 | 0 | ||
Ligand Pharmaceuticals Incorporated | COM NEW | 53220K504 | 10,049 | 73,386 | SH | SOLE | 73,386 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 6,910 | 363,676 | SH | SOLE | 363,676 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 56,514 | 615,684 | SH | SOLE | 615,684 | 0 | 0 | ||
MediWound Ltd. | ORD SHS | M68830104 | 1,006 | 226,000 | SH | SOLE | 226,000 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 22,504 | 1,160,014 | SH | SOLE | 1,160,014 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 46,528 | 2,549,461 | SH | SOLE | 2,549,461 | 0 | 0 | ||
Molecular Templates, Inc. | COM | 608550109 | 726 | 72,412 | SH | SOLE | 72,412 | 0 | 0 | ||
MyoKardia, Inc. | COM | 62857M105 | 14,957 | 355,264 | SH | SOLE | 355,264 | 0 | 0 | ||
Nabriva Therapeutics plc | SHS | G63637105 | 5,611 | 938,235 | SH | SOLE | 938,235 | 0 | 0 | ||
Natera, Inc. | COM | 632307104 | 2,056 | 228,676 | SH | SOLE | 228,676 | 0 | 0 | ||
Nektar Therapeutics | COM | 640268108 | 10,268 | 171,934 | SH | SOLE | 171,934 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 77,949 | 1,004,624 | SH | SOLE | 1,004,624 | 0 | 0 | ||
NewLink Genetics Corporation | COM | 651511107 | 8,169 | 1,007,273 | SH | SOLE | 1,007,273 | 0 | 0 | ||
Novavax, Inc. | COM | 670002104 | 2,480 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
Ovid Therapeutics Inc. | COM | 690469101 | 3,290 | 333,333 | SH | SOLE | 333,333 | 0 | 0 | ||
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 18,747 | 3,150,808 | SH | SOLE | 3,150,808 | 0 | 0 | ||
Proteon Therapeutics, Inc. | COM | 74371L109 | 567 | 298,591 | SH | SOLE | 298,591 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | COM | 74933V108 | 1,513 | 177,952 | SH | SOLE | 177,952 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 59,545 | 2,049,020 | SH | SOLE | 2,049,020 | 0 | 0 | ||
Rigel Pharmaceuticals, Inc. | COM NEW | 766559603 | 9,773 | 2,518,882 | SH | SOLE | 2,518,882 | 0 | 0 | ||
Ritter Pharmaceuticals, Inc. | COM | 767836109 | 922 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
Sage Therapeutics, Inc. | COM | 78667J108 | 101,546 | 616,514 | SH | SOLE | 616,514 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 34,659 | 2,113,376 | SH | SOLE | 2,113,376 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 2,446,317 | 45,725,556 | SH | SOLE | 45,725,556 | 0 | 0 | ||
Selecta Biosciences, Inc. | COM | 816212104 | 2,783 | 283,716 | SH | SOLE | 283,716 | 0 | 0 | ||
Spark Therapeutics, Inc. | COM | 84652J103 | 71,172 | 1,384,130 | SH | SOLE | 1,384,130 | 0 | 0 | ||
Spring Bank Pharmaceuticals, Inc. | COM | 849431101 | 5,015 | 373,144 | SH | SOLE | 373,144 | 0 | 0 | ||
Stemline Therapeutics, Inc. | COM | 85858C107 | 9,883 | 633,497 | SH | SOLE | 633,497 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | 2,737 | 741,665 | SH | SOLE | 741,665 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 5,593 | 574,835 | SH | SOLE | 574,835 | 0 | 0 | ||
T2 Biosystems, Inc. | COM | 89853L104 | 412 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Tenax Therapeutics, Inc. | COM | 88032L100 | 171 | 348,374 | SH | SOLE | 348,374 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | COM | 88165N105 | 5,891 | 935,000 | SH | SOLE | 935,000 | 0 | 0 | ||
Tonix Pharmaceuticals Holdings Corp. | COM | 890260409 | 2,413 | 699,500 | SH | SOLE | 699,500 | 0 | 0 | ||
Trevena, Inc. | COM | 89532E109 | 1,520 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
Trillium Therapeutics Inc. | COM NEW | 89620X506 | 2,968 | 409,323 | SH | SOLE | 409,323 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 9,453 | 482,557 | SH | SOLE | 482,557 | 0 | 0 | ||
Vanda Pharmaceuticals Inc. | COM | 921659108 | 6,443 | 423,884 | SH | SOLE | 423,884 | 0 | 0 | ||
Versartis, Inc. | COM | 92529L102 | 3,138 | 1,426,310 | SH | SOLE | 1,426,310 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 19,116 | 872,072 | SH | SOLE | 872,072 | 0 | 0 | ||
Acorda Therapeutics, Inc. | NOTE 1.75% 6/15/2021 | 00484MAA4 | 29,751 | 35,083,000 | PRN | SOLE | 35,083,000 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | NOTE 2.0% 8/15/2019 | 00767EAB8 | 7,566 | 9,517,000 | PRN | SOLE | 9,517,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.75% 10/15/2018 | 09061GAE1 | 13,218 | 12,228,000 | PRN | SOLE | 12,228,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 14,928 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
INOTEK Technologies Corp. | NOTE 5.75% 8/1/2021 | 45780VAB8 | 4,009 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
Novavax, Inc. | Note 3.75% 2/1/2023 | 670002AB0 | 40,863 | 88,500,000 | PRN | SOLE | 88,500,000 | 0 | 0 | ||
Protalix BioTherapeutics, Inc. | NOTE 4.5% 9/15/2018 | 74365AAB7 | 2,576 | 3,423,000 | PRN | SOLE | 3,423,000 | 0 | 0 |